Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Education
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry
Apr 02, 2025
Amyloid-reoriented enzyme catalysis
Apr 02, 2025
Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study
Apr 02, 2025
Incidental acute cholecystitis as a gateway to the diagnosis of AL cardiac amyloidosis
Apr 02, 2025
Role of Tag Team Rounds in Accurate Diagnosis and Management of Cardiac Amyloidosis
Apr 02, 2025
More in Education
Community Center
Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MD
Apr 05, 2025
Dottie’s Travel Alert for TAVR Patients
Apr 02, 2025
Advance Insulin Injection Technique and Education With FITTER Forward Expert Recommendations
Apr 01, 2025
Alnylam Presents New Data from the HELIOS-B Phase 3 Study of Vutrisiran in Patients with ATTR Amyloidosis with Cardiomyopathy (ATTR-CM) at the American College of Cardiology’s Annual Scientific Session 2025
Mar 31, 2025
Connecting with amyloidosis patients and caregivers in N.Z.
Mar 12, 2025
More in Community Center
News
Confirming the Benefit of SGLT2 Inhibitors in People With ATTR Amyloidosis, with Justin Riley Lam, MD
Apr 05, 2025
Senescence Accelerates the Occurrence of Dual Amyloidosis: Alzheimer's Disease and Wild-Type Transthyretin Amyloidosis
Apr 05, 2025
Vutrisiran improves cardiac amyloidosis endpoints regardless of disease severity
Apr 02, 2025
FDA Activity Recap: March 2025 Features FDA Approvals in Hemophilia, ATTR Amyloidosis, and More
Apr 01, 2025
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
Mar 31, 2025
More in News
Hot Topics
Healthy Meal Planning: Tips for Older Adults
Mar 12, 2025
An Elderly Mother and an Aging Son: A Journalist’s Caregiving Story
Mar 07, 2025
Supporting Family Caregivers in Providing Care
Mar 04, 2025
Live-In Caregivers for Elderly
Feb 26, 2025
The Hidden Cost of Caregiving: Stress, Anxiety, and Coping Mechanisms
Jan 23, 2025
Video